# Revision Log — Phase 6.5 Adversarial Review

---

# Round 1 Revision Log

**Date:** 2026-08-05T10:15:00Z
**Input Paper:** paper/06_paper.md
**Review File:** paper/review/065_review_r1.md
**Output Paper:** paper/06_paper_r1.md

---

## Issues Addressed

### FATAL Issues

*None.*

### MAJOR Issues

| ID | Title | Decision | Action Taken |
|----|-------|----------|--------------|
| MAJOR-CRED-002 | IRR margin discrepancy (+12.4% vs +11.5%) | ACCEPT | Fixed table entry in Section 5.1: "+12.4% margin" → "+11.5% margin". Calculation verified: (1.2263-1.1)/1.1 = 11.48% ≈ 11.5% |
| MAJOR-ENG-001 | Section 3.4 ends without forward bridge | ACCEPT | Added closing sentence: "Across all four predictions, BFGS convergence was confirmed; results are reported in Section 5 in causal-chain order (H-E1 → H-M1 → H-M2 → H-M3)." |
| MAJOR-CRED-003 | Reverse causality for continuous IV not in Limitations | ACCEPT | Added L6 to Section 6.3: covers potential reverse causality for log_tag_count (H-M2/H-M3), distinct from binary structural argument |
| MAJOR-CRED-001 | Conclusion 7.3 causal investment language | ACCEPT | Reframed closing recommendation from "highest-return investments" to "associated with substantially higher conditional adoption" with explicit causal caveat |

---

## Issues NOT Addressed

*None — all 4 MAJOR issues addressed.*

---

## MINOR Issues (collected for human review, NOT auto-fixed)

See `065_human_review_notes.md`.

---

## Sections Modified

- Section 3.4 Implementation: Added forward-pointing bridge sentence
- Section 5.1 Results Table: Fixed IRR margin from +12.4% to +11.5%
- Section 6.3 Limitations: Added L6 for continuous IV reverse causality
- Section 7.3 Closing: Reframed causal recommendation to predictive language

---

## Word Count Changes

| Section | Change | Delta |
|---------|--------|-------|
| Section 3.4 | Added 1 sentence | +~25 words |
| Section 5.1 | Fixed "12.4%" → "11.5%" | 0 net |
| Section 6.3 | Added L6 paragraph | +~60 words |
| Section 7.3 | Rewrote closing sentence | +~15 words |
| **Total** | | **~+100 words** |

---

# Round 2 Revision Log

**Date:** 2026-08-05T10:30:00Z
**Input Paper:** paper/06_paper_r1.md
**Review File:** paper/review/065_review_r2.md
**Output Paper:** paper/06_paper_r2.md

---

## Issues Addressed

### FATAL Issues

*None.*

### MAJOR Issues

| ID | Title | Decision | Action Taken |
|----|-------|----------|--------------|
| MAJOR-NUM-001 | H-M3 categorical CI/p-value table mismatch vs Phase 4 report | ACCEPT | Updated Section 5.4 table: CI values and p-values corrected to match h-m3/04_validation.md Phase 4 validated outputs. IRR values unchanged (consistent with ground truth). |

---

## Issues NOT Addressed

*None.*

---

## MINOR Issues (R2)

*None — no new minor issues in R2.*

---

## Sections Modified

- Section 5.4 Results Table: Updated 95% CI values and vs-reference p-values for bins 1-2, 3-5, 6+ to match Phase 4 validated output

---

## Word Count Changes

| Section | Change | Delta |
|---------|--------|-------|
| Section 5.4 | Table numerical corrections (no prose change) | 0 |
| **Total (R2)** | | **0 words** |

---

## Final Summary

**Total Revisions Made:** 5 MAJOR issues addressed across 2 rounds
**Sections Modified:** Section 3.4, 5.1, 5.4, 6.3, 7.3

**Review Process:**
- Started: 2026-08-05T10:00:00Z
- Completed: 2026-08-05T10:35:00Z
- Rounds: 2 (R1: structural; R2: numerical verification)
- Personas Used: accuracy_checker, bored_reviewer, skeptical_expert

**Files Generated:**
- `paper/06_paper_final.md` (final paper with review metadata)
- `paper/review/065_review_summary.md` (review summary)
- `paper/review/065_human_review_notes.md` (6 MINOR issues for human review)
- `paper/review/065_changelog.md` (this file)
- `paper/review/065_review_r1.md` (Round 1 adversary report)
- `paper/review/065_review_r2.md` (Round 2 adversary report)
- `paper/06_paper_r1.md` (R1 revised paper)
- `paper/06_paper_r2.md` (R2 revised paper)

**Next Phase:** Phase 6.5.1 (Overleaf LaTeX/PDF generation)
